2-(4-bromo-2,5-dimethoxyphenyl)ethylamine and 4-iodo-2,5-dimethoxy-beta-phenethylamine

2-(4-bromo-2,5-dimethoxyphenyl)ethylamine has been researched along with 4-iodo-2,5-dimethoxy-beta-phenethylamine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Clare, BW	1
Hegarty, CB; Janis, GC; Kealey, SE; Stellpflug, SJ	1
Halberstadt, AL	1
Cocchi, V; Gasperini, S; Hrelia, P; Lenzi, M; Marti, M; Tirri, M	1

Reviews

1 review(s) available for 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine and 4-iodo-2,5-dimethoxy-beta-phenethylamine

Article	Year
Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Current topics in behavioral neurosciences, 2017, Volume: 32 Topics: Animals; Dimethoxyphenylethylamine; Ethylamines; Fever; Hallucinogens; Humans; Iodobenzenes; Mice; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rhabdomyolysis; Seizures; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Vasoconstriction	2017

Article

Year

Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.

Current topics in behavioral neurosciences, 2017, Volume: 32

Topics: Animals; Dimethoxyphenylethylamine; Ethylamines; Fever; Hallucinogens; Humans; Iodobenzenes; Mice; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Rhabdomyolysis; Seizures; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship; Vasoconstriction

2017

Other Studies

3 other study(ies) available for 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine and 4-iodo-2,5-dimethoxy-beta-phenethylamine

Article	Year
The frontier orbital phase angles: novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens. Journal of medicinal chemistry, 1998, Sep-24, Volume: 41, Issue:20 Topics: Hallucinogens; Humans; Models, Molecular; Molecular Conformation; Phenethylamines; Quantum Theory	1998
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2014, Volume: 10, Issue:1 Topics: Adolescent; Benzylamines; Biomarkers; Biotransformation; Designer Drugs; Dimethoxyphenylethylamine; Epilepsy, Tonic-Clonic; Female; Hallucinogens; Humans; Minnesota; Neurotoxicity Syndromes; Phenethylamines; Substance Abuse Detection; Treatment Outcome	2014
Novel Psychoactive Phenethylamines: Impact on Genetic Material. International journal of molecular sciences, 2020, Dec-17, Volume: 21, Issue:24 Topics: Anisoles; Apoptosis; Cell Line; Cell Survival; Dimethoxyphenylethylamine; Flow Cytometry; Genes; Hallucinogens; Humans; Micronuclei, Chromosome-Defective; Micronucleus Tests; N-Methyl-3,4-methylenedioxyamphetamine; Phenethylamines; Psychotropic Drugs; Reactive Oxygen Species	2020